Cleveland Biolabs (CBLI) Submits pre-EUA to FDA for Entolimod as Medical Radiation Countermeasure
Tweet Send to a Friend
Cleveland Biolabs (NASDAQ: CBLI) announced that the company has submitted an application for pre-Emergency Use Authorization (pre-EUA) to the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
